P02.07 Trial in progress: anti-PD1, capecitabine, and oxaliplatin for the first-line treatment of dMMR esophagogastric cancer (AuspiCiOus-dMMR): a proof-of-principle study (AuspiCiOus)

Bibliografske podrobnosti
Main Authors: HWM van Laarhoven, J Bos, N Haj Mohammad, S Derks
Format: Article
Jezik:English
Izdano: BMJ Publishing Group 2024-03-01
Serija:Journal for ImmunoTherapy of Cancer